Compare Stocks

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

Sonoro Metals Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Mexico and the United States. It primarily explores for gold and silver. The company holds interest in the San Marcial project covering an area of approximately 1,000 hectares located in Sonora, Mexico. It also has an option to earn a 60% interest in the Hilltop Gold project consisting of 12,836 hectares located in southeast of Fairbanks, Alaska; and a 100% interest in the Calera Group of Concessions that covers an area of approximately 1,500 hectares located in the municipality of Cucurpe, Mexico. The company was formerly known as Becker Gold Mines Ltd. and changed its name to Sonoro Metals Corp. in January 2012. Sonoro Metals Corp. is headquartered in Vancouver, Canada.

Suroco Energy Inc. (Suroco) is a junior oil and gas company, which explores for, develops and sells crude oil, natural gas liquids and natural gas in Colombia. The Company holds working interests in the four oil and gas blocks in Colombia: Alea 1848 A Block (50%), Alea 1947 C Block (49.5%), Suroriente Block (15.8%), and Hato Nuevo Block (9.9%). The Suroriente Block (36,528 hectares) is located in the southeast sector of the Putumayo Basin. The Suroriente Block is producing approximately 10,048 barrels per day on a gross basis from 14 wells. The Alea 1848-A Block has a total area of approximately 30,600 hectares and it is located northwest of the Suroriente Block. The Alea 1947-C Block has a total area of approximately 23,500 hectares and is located northeast of the Suroriente Block. The Company has one wholly owned subsidiary Suroco Energy S.L.U. (SES). SES has one wholly owned subsidiary NCT P&G Corp. Effective July 15, 2014, PetroAmerica Oil Corp acquired Suroco Energy Inc.

The Global X S&P 500 Tail Risk ETF (XTR) is an exchange-traded fund that is based on the Cboe S&P 500 Tail Risk index. The fund tracks an index of the S&P 500 stocks and aims to protect the fund from significant negative movements or tail risk by purchasing quarterly Index put options. XTR was launched on Aug 25, 2021 and is managed by Global X.